Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C26H36N2O4 |
| Molecular Weight | 440.575 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1OC)[C@](CCCNCCC2=CC(OC)=C(OC)C=C2)(C#N)C(C)C
InChI
InChIKey=UPKQNCPKPOLASS-AREMUKBSSA-N
InChI=1S/C26H36N2O4/c1-19(2)26(18-27,21-9-11-23(30-4)25(17-21)32-6)13-7-14-28-15-12-20-8-10-22(29-3)24(16-20)31-5/h8-11,16-17,19,28H,7,12-15H2,1-6H3/t26-/m1/s1
Arverapamil (brand name Rezular), a modulator of melatonin and serotonin receptors, was developed by Ireland-based company, AGI Therapeutics. The drug participated in phase III of clinical trials for patients to treat the irritable bowel syndrome with diarrhea, the trial was discontinued because the drug didn’t meet the primary endpoint.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
123932-43-4
Created by
admin on Mon Mar 31 21:36:52 GMT 2025 , Edited by admin on Mon Mar 31 21:36:52 GMT 2025
|
PRIMARY | |||
|
DTXSID601316844
Created by
admin on Mon Mar 31 21:36:52 GMT 2025 , Edited by admin on Mon Mar 31 21:36:52 GMT 2025
|
PRIMARY | |||
|
15593907
Created by
admin on Mon Mar 31 21:36:52 GMT 2025 , Edited by admin on Mon Mar 31 21:36:52 GMT 2025
|
PRIMARY | |||
|
3J8P56R04P
Created by
admin on Mon Mar 31 21:36:52 GMT 2025 , Edited by admin on Mon Mar 31 21:36:52 GMT 2025
|
PRIMARY | |||
|
DB06669
Created by
admin on Mon Mar 31 21:36:52 GMT 2025 , Edited by admin on Mon Mar 31 21:36:52 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
